The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-line brentuximab vedotin plus chemotherapy to improve overall survival in patients with stage III/IV classical Hodgkin lymphoma: An updated analysis of ECHELON-1.
 
Stephen M. Ansell
Honoraria - Research to Practice; WebMD
Research Funding - ADC Therapeutics (Inst); Affimed Therapeutics (Inst); AI Therapeutics (Inst); Bristol-Myers Squibb (Inst); Regeneron (Inst); Seagen (Inst); Trillium Therapeutics (Inst)
 
Joseph M. Connors
Patents, Royalties, Other Intellectual Property - Evaluation of mantle cell lymphoma and methods related thereof (Inst); Methods for selecting and treating lymphoma types (Inst)
 
John A. Radford
Stock and Other Ownership Interests - ADC Therapeutics; AstraZeneca (I)
Honoraria - ADC Therapeutics; Takeda
Consulting or Advisory Role - Novartis; Seagen; Takeda
Speakers' Bureau - Novartis; Seagen; Takeda
Research Funding - Takeda
Travel, Accommodations, Expenses - ADC Therapeutics; Takeda
 
Won Seog Kim
No Relationships to Disclose
 
Andrea Gallamini
Honoraria - Takeda
Consulting or Advisory Role - Takeda
 
Radhakrishnan Ramchandren
Consulting or Advisory Role - Seagen
Research Funding - Seagen (Inst)
 
Jonathan W. Friedberg
Research Funding - Enterome (Inst)
Patents, Royalties, Other Intellectual Property - Patient on bone marrow microenvironment signals (I)
 
Ranjana H. Advani
Consulting or Advisory Role - ADC Therapeutics; Bristol-Myers Squibb/Celgene; Daiichi Sankyo; Epizyme; Genentech/Roche; Incyte; Karyopharm Therapeutics; Kura Oncology; Merck; Sanofi; Takeda
Research Funding - cyteir (Inst); Forty Seven (Inst); Genentech/Roche (Inst); Janssen (Inst); Kura Oncology (Inst); Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Regeneron (Inst); Seagen (Inst)
 
Martin Hutchings
Consulting or Advisory Role - Genmab; Janssen; Roche; Takeda
Research Funding - Celgene (Inst); Genmab (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst)
 
Andrew M. Evens
Honoraria - Abbvie/Pharmacyclics; Cota Healthcare; Curio Science; Epizyme; HMP; HUTCHMED; Incyte; Miltenyi Biotec; MorphoSys; Novartis; OncLive Clinical Congress Consultants; Patient Power; PER; Pharmacyclics; Research to Practice; Seagen; Takeda; Targeted Oncology; WebMD
Consulting or Advisory Role - Abbvie; Cota Healthcare; Epizyme; Incyte; Miltenyi Biotec; MorphoSys; Novartis; Pharmacyclics; Seagen
Speakers' Bureau - Curio Science; Research to Practice
Travel, Accommodations, Expenses - Curio Science; Novartis; Seagen
 
Piotr Smolewski
Honoraria - Roche; Takeda
Travel, Accommodations, Expenses - Roche; Takeda
 
Kerry J. Savage
Honoraria - Abbvie; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Kyowa; Merck; Novartis; Novartis; Novartis Canada Pharmaceuticals Inc; Seagen
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Merck; Seagen; Servier
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Seagen
(OPTIONAL) Uncompensated Relationships - Beigene
 
Nancy L. Bartlett
Consulting or Advisory Role - Acerta Pharma; ADC Therapeutics; BTG; Roche/Genentech; Seagen
Research Funding - ADC Therapeutics (Inst); Affimed Therapeutics (Inst); Autolus (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Forty Seven (Inst); Immune Design (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Merck (Inst); Millennium (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche/Genentech (Inst); Seagen (Inst)
 
Hyeon Seok Eom
Research Funding - Takeda
 
Jeremy S. Abramson
Honoraria - AstraZeneca; Janssen; Regeneron
Consulting or Advisory Role - Abbvie; Alimera Sciences; AstraZeneca; BeiGene; Bluebird Bio; Bristol-Myers Squibb; C4 Therapeutics; Celgene; Century Therapeutics; Century Therapeutics; EMD Serono; Epizyme; Genentech; Genmab; Incyte; Karyopharm Therapeutics; Kite, a Gilead company; Kymera; Lilly; MorphoSys; MorphoSys; MustangBio; Novartis; Ono Pharmaceutical
Research Funding - AI Therapeutics (Inst); Bristol-Myers Squibb/Celgene (Inst); Seagen (Inst)
 
Cassie Dong
Employment - Takeda
Stock and Other Ownership Interests - Seagen; Takeda
 
Frank Campana
Employment - Takeda
Stock and Other Ownership Interests - Takeda
 
Keenan Fenton
Employment - Seagen
Stock and Other Ownership Interests - Seagen
Travel, Accommodations, Expenses - Seagen
 
Markus Puhlmann
Employment - Seagen
Leadership - Seagen
Stock and Other Ownership Interests - Seagen
Travel, Accommodations, Expenses - Seagen
 
David J. Straus
Consulting or Advisory Role - Epizyme; Seagen; Takeda
Research Funding - Takeda (Inst)